loading
Schlusskurs vom Vortag:
$1.06
Offen:
$1.055
24-Stunden-Volumen:
42,638
Relative Volume:
0.03
Marktkapitalisierung:
$14.75M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-17.93M
KGV:
-0.6045
EPS:
-1.77
Netto-Cashflow:
$-14.28M
1W Leistung:
+2.88%
1M Leistung:
+0.94%
6M Leistung:
-33.54%
1J Leistung:
-45.82%
1-Tages-Spanne:
Value
$1.05
$1.10
1-Wochen-Bereich:
Value
$1.01
$1.10
52-Wochen-Spanne:
Value
$0.90
$3.26

Cocrystal Pharma Inc Stock (COCP) Company Profile

Name
Firmenname
Cocrystal Pharma Inc
Name
Telefon
(786) 459-1831
Name
Adresse
19805 N. CREEK PARKWAY, BOTHELL, WA
Name
Mitarbeiter
11
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
COCP's Discussions on Twitter

Vergleichen Sie COCP mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
COCP
Cocrystal Pharma Inc
1.07 14.61M 0 -17.93M -14.28M -1.77
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
444.64 110.88B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
726.21 72.79B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
890.11 54.76B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
404.46 54.85B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
INSM
Insmed Inc
189.85 41.41B 447.02M -1.18B -906.14M -6.1812

Cocrystal Pharma Inc Stock (COCP) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2020-07-08 Eingeleitet H.C. Wainwright Buy

Cocrystal Pharma Inc Aktie (COCP) Neueste Nachrichten

pulisher
Dec 06, 2025

Revenue per share of Cocrystal Pharma Inc – FWB:8CC - TradingView

Dec 06, 2025
pulisher
Dec 04, 2025

Why institutional investors increase stakes in Cocrystal Pharma Inc. (8CC) stockJuly 2025 Review & AI Optimized Trade Strategies - Newser

Dec 04, 2025
pulisher
Dec 02, 2025

Published on: 2025-12-02 05:48:00 - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

How Cocrystal Pharma Inc. (8CC) stock valuation compares with sectorBond Market & Reliable Price Breakout Signals - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

How Cocrystal Pharma Inc. (8CC) stock behaves under inflation pressureWeekly Market Summary & Weekly High Return Opportunities - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

Is Cocrystal Pharma Inc. (8CC) stock among top earnings playsMarket Risk Analysis & Expert-Curated Trade Recommendations - Newser

Dec 02, 2025
pulisher
Dec 01, 2025

Cocrystal Pharma to Present at Emerging Growth Conference - TipRanks

Dec 01, 2025
pulisher
Dec 01, 2025

Cocrystal Pharma to Present at Noble Capital Markets Conference - TradingView

Dec 01, 2025
pulisher
Dec 01, 2025

COCP Insider Trading - Quiver Quantitative

Dec 01, 2025
pulisher
Dec 01, 2025

Cocrystal Pharma, Inc. to Present Clinical Progress Update at NobleCon 21 Conference - Quiver Quantitative

Dec 01, 2025
pulisher
Dec 01, 2025

Cocrystal Pharma (Nasdaq: COCP) to present company overview at NobleCon 21 on Dec. 3, 2025 - Stock Titan

Dec 01, 2025
pulisher
Nov 28, 2025

Phillip Frost buys Cocrystal Pharma (COCP) shares worth $3975 By Investing.com - Investing.com South Africa

Nov 28, 2025
pulisher
Nov 28, 2025

Phillip Frost buys Cocrystal Pharma (COCP) shares worth $3975 - Investing.com

Nov 28, 2025
pulisher
Nov 26, 2025

Phillip Frost buys Cocrystal Pharma (COCP) shares worth $18,812 - Investing.com India

Nov 26, 2025
pulisher
Nov 25, 2025

Phillip Frost buys Cocrystal Pharma (COCP) shares worth $18,812 By Investing.com - Investing.com Australia

Nov 25, 2025
pulisher
Nov 25, 2025

COCP insider Phillip Frost updates holdings after 20,000-share trade - Stock Titan

Nov 25, 2025
pulisher
Nov 23, 2025

What analysts say about Cocrystal Pharma Inc 8CC stockSector-Based Investing & High Profit Trading Alerts - earlytimes.in

Nov 23, 2025
pulisher
Nov 21, 2025

Zacks Small Cap Has Bullish Outlook for COCP FY2025 Earnings - Defense World

Nov 21, 2025
pulisher
Nov 20, 2025

Cocrystal Pharma Inc. (COCP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 20, 2025
pulisher
Nov 20, 2025

Is Cocrystal Pharma Inc. stock vulnerable to regulatory risksWeekly Stock Analysis & Real-Time Buy Zone Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Is Cocrystal Pharma Inc. stock a top momentum playPortfolio Value Report & Risk Managed Trade Strategies - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Can Cocrystal Pharma Inc. (8CC) stock sustain double digit ROEJuly 2025 PreEarnings & Weekly Breakout Opportunity Watchlist - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Why Cocrystal Pharma Inc. (8CC) stock remains stableJuly 2025 Sector Moves & Low Risk High Win Rate Stock Picks - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Is Cocrystal Pharma Inc. stock attractive for long term wealth buildingMarket Activity Recap & Verified Entry Point Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Does Cocrystal Pharma Inc. qualify in momentum factor screeningQuarterly Trade Summary & Intraday High Probability Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Cocrystal Pharma Inc. stock pay special dividends2025 Bull vs Bear & High Accuracy Trade Signal Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Cocrystal Pharma Inc. stock sustain revenue growthWeekly Gains Report & Community Consensus Trade Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Cocrystal Pharma Inc. stock maintain operating margins2025 Short Interest & Risk Adjusted Swing Trade Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can machine learning forecast Cocrystal Pharma Inc. recovery2025 Market Overview & Fast Exit/Entry Strategy Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Cocrystal Pharma Inc 8CC a good long term investmentHigh Beta Stocks & Predict Price Movements With AI Precision - earlytimes.in

Nov 19, 2025

Finanzdaten der Cocrystal Pharma Inc-Aktie (COCP)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$38.26
price up icon 0.45%
$95.17
price up icon 0.01%
$31.24
price up icon 1.00%
$95.73
price down icon 0.12%
biotechnology ONC
$322.68
price up icon 1.25%
$189.85
price down icon 2.22%
Kapitalisierung:     |  Volumen (24h):